Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
A systematic review of matched cohort and case-control studies was performed to examine the mortality attributable to candidemia. The review included studies that compared mortality of patients with candidemia (cases) to that of matched patients without candidemia (controls). Secondary variables examined were the length and cost of hospital stay. Relevant studies were identified using the PubMed database and by examining the references of the initially selected studies. Two independent reviewers performed the literature search, study selection and data extraction from the identified studies. A total of seven studies were included in the review. The patients included those hospitalized in intensive care units (ICU) and hospital wards and those undergoing transplantation. The mortality attributed to candidemia in the reviewed studies ranged from 5 to 71%. For six of the reviewed studies the difference in mortality between cases and controls was statistically significant. Among those who survived, the length of stay and the cost of hospitalization of patients with candidemia were significantly higher than those of controls. Despite the methodological heterogeneity of the reviewed studies, the data from the available matched cohort and case-control studies suggest that candidemia is associated with considerable mortality that is attributed, at least to some degree, to the infection itself and not only to the presence of another comorbidity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Estimates of mortality attributable to candidemia range from 5% to 71%, varying based on setting, age group, and study design [10].”
From Burden of Candidemia in the United States, 2017 (2020) · cites this paper as [10]
In the citing paper
“The mortality attributed to candidemia, in the reviewed studies, ranged from 5 to 71%, and for six, the difference in mortality between cases and controls was statistically significant.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [14]
Citations
Cites
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 1×
“It should be noted, as also stated by the authors of the study, that this definition is not in accordance with the Infectious Diseases Society of America (IDSA) guidelines for treatment of candidiasis [19]; these consider treatment for candidemia adequate if amphotericin B, fluconazole or caspofungin continues for 2 w…”
ResultNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286 · cited 1×
“This is also stressed in other articles [17, 18].”
ResultSecular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Sague, C. M. B., Jarvis, W. R., & System, N. N. I. S. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140 · cited 8×
“It is also interesting that when the results were analyzed using matched-pair analysis, the difference between cases and controls in the median number of days spent in hospital was further augmented [12, 13].”
BackgroundResultInfluential(1999) · American Journal of Infection Control · doi:10.1016/s0196-6553(99)70031-3 · Cited by 901
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831 · cited 8×
“[13] performed matching according to disease severity.”
BackgroundResultInfluentialZaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C. (2005) · Clinical Infectious Diseases · doi:10.1086/496922 · Cited by 784 · cited 7×
“length of hospital stay of adult cases was more than double that of controls [10].”
BackgroundMethodResultInfluentialTrick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Epidemiology of Nosocomial Fungal Infections, with Emphasis on Candida Species
Jarvis, W. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1526 · Cited by 636
Nosocomial Candidemia: Risk Factors and Attributable Mortality
Wenzel, R. P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1531 · Cited by 502 · cited 1×
“Due to the poor prognosis of patients with candidemia, it is difficult to distinguish mortality attributable directly to candidemia from that caused by the underlying disease [8].”
BackgroundDiGIOVINE, B., CHENOWETH, C., WATTS, C., & HIGGINS, M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9808145 · Cited by 449 · cited 1×
“In addition, even if adequate matching of cases and controls was accomplished during hospital or ICU admission of the patients, previous studies have shown that ICU patients who developed candidemia had a substantially greater severity of illness between the day of ICU admission and the day of candidemia development […”
ResultMorgan, J., Meltzer, M. I., Plikaytis, B. D., Sofair, A. N., Huie-White, S., Wilcox, S., Harrison, L. H., Seaberg, E. C., Hajjeh, R. A., & Teutsch, S. M. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502581 · Cited by 437 · cited 5×
“One study reported results on the length of hospital stay for patients with candidemia compared with that of a hypothetical patient with specific baseline characteristics using a multivariable linear regression model [9].”
BackgroundResultInfluentialImpact of the changing epidemiology of fungal infections in the 1990s
Pfaller, M., & Wenzel, R. (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01962067 · Cited by 238
Effects of nosocomial candidemia on outcomes of critically ill patients
Blot, S. I., Vandewoude, K. H., Hoste, E. A., & Colardyn, F. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01248-2 · Cited by 235 · cited 5×
“Five of the studies included mixed hospital populations [9, 10, 12, 13, 15], one [11] included ICU patients only and one [14] liver transplant recipients.”
BackgroundResultInfluentialNieto-Rodriguez, J. A., Kusne, S., Mañez, R., Irish, W., Linden, P., Magnone, M., Wing, E. J., Fung, J. J., & Starzl, T. E. (1996) · Annals of Surgery · doi:10.1097/00000658-199601000-00010 · Cited by 111 · cited 1×
“Five of the studies included mixed hospital populations [9, 10, 12, 13, 15], one [11] included ICU patients only and one [14] liver transplant recipients.”
ResultHas the Epidemiology of Nosocomial Candidemia Changed?
Puzniak, L., Teutsch, S., Powderly, W., & Polish, L. (2004) · Infection Control & Hospital Epidemiology · doi:10.1086/502452 · Cited by 80
Estimating Attributable Mortality of Candidemia: Clinical Judgement vs. Matched Cohort Studies
Blot, S. I., & Vandewoude, K. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-0885-7 · Cited by 16 · cited 1×
“This is also stressed in other articles [17, 18].”
ResultFactors Influencing Outcome in Hospitalized Patients with Candidemia
Caroll, K., Jeppson, K. G., Readin, J., & Reimer, L. G. (1993) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-199307000-00006 · Cited by 7
Cited by
-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538
“mortality rate associated with IFIs is considerably high [7].”
BackgroundSelf-citationPfaller, M., Neofytos, D., Diekema, D., Azie, N., Meier-Kriesche, H.-U., Quan, S.-P., & Horn, D. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.10.003 · Cited by 394
“In the present series, survival appeared to have improved, compared with that in many older studies (Falagas et al., 2006; Gudlaugsson et al., 2003; Wey et al., 1988; Zaoutis et al., 2005).”
ResultKett, D. H., Azoulay, E., Echeverria, P. M., & Vincent, J.-L. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318206c1ca · Cited by 389
“1%, respectively) and longer intensive care unit lengths of stay (median [interquartile range]) (33 days [18–44], 20 days [9–43], and 21 days [8–46], respectively); however, these differences were not statistically significant.”
BackgroundInvasive candidiasis as a cause of sepsis in the critically ill patient
Delaloye, J., & Calandra, T. (2014) · Virulence · doi:10.4161/viru.26187 · Cited by 372
“The attributable mortality of invasive candidiasis was reported to be somewhere between 5% and 71%.(16,19,20) This wide range probably reflects the inherent difficulty of assessing whether these critically ill patients died either with or from fungal infections.”
BackgroundFalagas, M. E., Roussos, N., & Vardakas, K. Z. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.04.006 · Cited by 346
Self-citation
Metadata
- Authors
- Falagas, M. E., Apostolou, K. E., & Pappas, V. D.
- Affiliations
- Tufts University (US)
- Alfa Institute of Biomedical Sciences (GR)
- Corresponding author
- Falagas, M. E.
- ORCID
- Falagas, M. E.
- Venue
- European Journal of Clinical Microbiology & Infectious Diseases
- Published
- 2006-06-14
- Volume
- 25
- Issue
- 7
- Pages
- 419-425
- ISSN
- 0934-9723 (ISSN-L)
- 1435-4373
- OpenAlex
- W2089115810
- Semantic Scholar
- aeb27cd38dec2cc6bc8a111d9effed9e8eb45139
- Cited by
- 294
- References
- 21
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 10 · 2023: 8 · 2022: 11 · 2021: 12 · 2020: 14 · 2019: 13 · 2018: 11 · 2017: 13 · 2016: 22 · 2015: 21 · 2014: 20 · 2013: 16 · 2012: 17
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Clinical Microbiology & Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, attributable mortality, invasive fungal infections, length of hospital stay, hospital costs, intensive care unit patients, transplant recipients, comorbidities
- MeSH terms
- Adult, Candida, Candidiasis, Child, Hospitalization, Humans, Length of Stay, Cohort Studies, Case-Control Studies, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.